Government Slashes Trade Margins on Cancer Drugs

The Indian government has capped the profit margins on many cancer medicines at 30% to make life-saving treatments more affordable for patients. This new rule applies to both branded and generic drugs, whether made in India or imported, and is expected to save patients around ₹500 crores every year. The move follows concerns from the … Read more